Surprises of genetic engineering: A possible model of polyglucosan body diseaseRABEN, N; DANON, M; DIMAURO, S et al.Neurology. 2001, Vol 56, Num 12, pp 1739-1745, issn 0028-3878Article

Clinical features and new molecular findings in Camitine Palmitoyltransferase II (CPT II) deficiencyCORTI, S; BORDONI, A; RONCHI, D et al.Journal of the neurological sciences. 2008, Vol 266, Num 1-2, pp 97-103, issn 0022-510X, 7 p.Article

Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosumCRIMELLA, C; ARNOLDI, A; TOSCANO, A et al.Journal of medical genetics. 2009, Vol 46, Num 5, pp 345-351, issn 0022-2593, 7 p.Article

Management and treatment of glycogenosis type IIBEMBI, B; CERINI, E; TOSCANO, A et al.Neurology. 2008, Vol 71, Num 23, issn 0028-3878, S12-S36, SUP2Conference Paper

Familial cerebellar ataxia with muscle coenzyme Q10 deficiencyMUSUMECI, O; NAINI, A; DE VIVO, D. C et al.Neurology. 2001, Vol 56, Num 7, pp 849-855, issn 0028-3878Article

A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle diseaseFERNANDEZ, R; NAVARRO, C; MUSUMECI, O et al.Archives of neurology (Chicago). 2000, Vol 57, Num 2, pp 217-219, issn 0003-9942Article

Apoptosis in metabolic myopathiesMONICI, M. C; TOSCANO, A; GIRLANDA, P et al.Neuroreport (Oxford). 1998, Vol 9, Num 10, pp 2431-2432, issn 0959-4965Article